Literature DB >> 15783120

Fibrosing cholestatic hepatitis in renal transplant recipient with CMV infection: a case report.

S K Agarwal1, V Kalra, Amit Dinda, S Gupta, S C Dash, D Bhowmik, S C Tiwari.   

Abstract

Fibrosing cholestatic hepatitis (FCH) is an uncommon complication of renal transplantation. It is usually associated with hepatitis B and C viral infection. It is further rare in renal transplantation in absence of HBV and HCV infection. To the best of our knowledge, only three cases of FCH in renal transplantation, which were both HBV and HCV negative, have been reported to date. Out of these, two cases were diagnosed to have CMV infection and the third was attributed to azathioprin. We are presenting another case of FCH in a renal transplant recipient with CMV infection.

Entities:  

Mesh:

Year:  2004        PMID: 15783120     DOI: 10.1007/s11255-004-6196-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  18 in total

1.  Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient.

Authors:  Y S Shan; P C Lee; J R Wang; H P Tsai; C M Sung; Y T Jin
Journal:  Nephrol Dial Transplant       Date:  2001-12       Impact factor: 5.992

Review 2.  Hepatitis C viral infection in the immunosuppressed patient.

Authors:  J Collier; J Heathcote
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

3.  Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation.

Authors:  L K Schluger; P A Sheiner; S N Thung; J Y Lau; A Min; D C Wolf; I Fiel; D Zhang; M A Gerber; C M Miller; H C Bodenheimer
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

4.  Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation.

Authors:  H Zylberberg; F Carnot; M F Mamzer; G Blancho; C Legendre; S Pol
Journal:  Transplantation       Date:  1997-01-15       Impact factor: 4.939

5.  Fibrosing cholestatic hepatitis-like syndrome in a hepatitis B virus and hepatitis C virus-negative renal transplant recipient: a case report with autopsy findings.

Authors:  Ajay Duseja; Ritambhara Nada; Naveen Kalra; S K Acharya; M Minz; K Joshi; Yogesh Chawla
Journal:  Trop Gastroenterol       Date:  2003 Jan-Mar

6.  Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy.

Authors:  C M Toth; M Pascual; R T Chung; F Graeme-Cook; J L Dienstag; A K Bhan; A B Cosimi
Journal:  Transplantation       Date:  1998-11-15       Impact factor: 4.939

7.  Veno-occlusive hepatic disease of the liver in renal transplantation: is azathioprine the cause?

Authors:  F Liaño; A Moreno; R Matesanz; J L Teruel; C Redondo; F García-Martín; L Orte; J Ortuño
Journal:  Nephron       Date:  1989       Impact factor: 2.847

8.  Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation.

Authors:  C H Chen; P J Chen; J S Chu; K H Yeh; M Y Lai; D S Chen
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

9.  Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.

Authors:  S E Davies; B C Portmann; J G O'Grady; P M Aldis; K Chaggar; G J Alexander; R Williams
Journal:  Hepatology       Date:  1991-01       Impact factor: 17.425

10.  Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant.

Authors:  J C Booth; R D Goldin; J L Brown; P Karayiannis; H C Thomas
Journal:  J Hepatol       Date:  1995-04       Impact factor: 25.083

View more
  4 in total

1.  Clinicopathological conference: fibrosing cholestatic hepatitis presenting as subacute hepatic failure in a non-transplant patient.

Authors:  Ajay Duseja; Ashim Das; Y K Chawla; Anil Bhansali; V Sakhuja
Journal:  Dig Dis Sci       Date:  2009-07-23       Impact factor: 3.199

2.  Fibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis and pathogenesis.

Authors:  Shu-Yuan Xiao; Liang Lu; Hanlin L Wang
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 3.  Systemic causes of cholestasis.

Authors:  Andrew S Delemos; Lawrence S Friedman
Journal:  Clin Liver Dis       Date:  2013-01-26       Impact factor: 6.126

4.  Successful treatment of fibrosing cholestatic hepatitis following kidney transplantation with allogeneic hematopoietic stem cell transplantation: a case report.

Authors:  Dong Liang Li; Jian Fang; Zhiyong Zheng; Weizhen Wu; Zhixian Wu
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.